
Unqualified for Singapore posting: Senate grills Trump's pick Anjani Sinha
During the confirmation hearing by the Senate's foreign relations committee, he was introduced by Republican Senator Lindsey Graham as "a friend of President Trump for over a decade", according to the BBC.In his introduction and responses to senators' questions, Sinha described himself as a "lifelong bridge builder" and pledged to "create a very strong relationship with Singapore" while vowing to "defend the defence, security, and economic ties".SINHA GAVE INCORRECT NUMBERS ON TRADE TIES WITH SINGAPOREDuckworth opened her questioning by asking Sinha about Singapore's trade surplus with the US, to which he first responded with $80 billion (Rs 6.68 lakh crore), before changing his answer to $18 billion (Rs 1.50 lakh crore).Eventually, Duckworth noted the correct figure was $2.8 billion (Rs 23,380 crore).When asked how he would justify Trump's 10% tariff, imposed in April, to Singaporeans, Sinha gave multiple responses before concluding that "the dialogue is not closed".During the hearing, Sinha mistakenly stated that Malaysia currently chairs ASEAN and did not know that Singapore is set to take over the role in 2027."You are unqualified for this position," Senator Duckworth said during the hearing. She added that he needed to "shape up and do some homework.""You've not even done your homework, sir," Duckworth said."You think this is a glamour posting, that you're going to live a nice life in Singapore, when what we need is someone who can actually do the work," BBC quoted her as saying.Noting that Singapore is a key US ally in the Indo-Pacific, Duckworth said, "You are not currently prepared for this posting, period, and you need to shape up and do some homework."The exchange sparked a wave of online criticism from Singaporeans, with many questioning Sinha's performance and his suitability for the role of US ambassador.According to the BBC report, despite the controversy, Sinha's confirmation remains a strong possibility.WHO IS ANJANI SINHA?Anjani Sinha was born in India and is a graduate of MGM Medical School and Delhi University. He has a Masters in orthopaedic surgery, according to the US State Department.advertisementSinha is a distinguished surgeon on the US East Coast specialising in orthopaedics and sports medicine. He is an accomplished entrepreneur, and has served as a senior surgical consultant in Florida.The State Department also said that Sinha has native respect for both American and Asian values, and has deep social and cultural ties to the Indo-Pacific region. Hence, he is uniquely positioned to relate to key stakeholders.His appreciation for Singapore's role as a financial hub, and his own business expertise – particularly in the life sciences and healthcare sectors – render him well qualified to serve as US Ambassador to Singapore, the State Department also said.- Ends
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
26 minutes ago
- Hans India
PLI schemes see actual investment of Rs 1.76 lakh crore, create over 12 lakhs jobs: Minister
New Delhi: The production-linked incentive (PLI) schemes have realised actual investment of Rs. 1.76 lakh crore till March 2025 across 14 sectors, which has resulted in incremental production/sales of over Rs. 16.5 lakh crore and employment generation of over 12 lakhs (direct and indirect), the Parliament was informed on Tuesday. To date, 806 applications have been approved under PLI schemes across 14 sectors. These schemes have incentivized domestic manufacturing, leading to increased production, job creation and a boost in exports, said Minister of State for Commerce and Industry, Jitin Prasada, in a written reply to the Lok Sabha. The pharmaceuticals sector has witnessed cumulative sales of Rs 2.66 lakh crore which includes exports of Rs 1.70 lakh crore achieved in the first three years of the scheme. The scheme has contributed to India becoming a net exporter of bulk drugs (Rs 2,280 crore) from net importer (-1,930 crore) as was the case in FY 2021-22. It has also resulted in significant reduction in gap between the domestic manufacturing capacity and demand of critical drugs. Under the PLI Scheme for medical devices, 21 projects have started manufacturing of 54 unique medical devices, which include high end devices such as Linear Accelerator (LINAC), MRI, CT-Scan, Heart Valve, Stent, Dialyzer Machine, C-Arm, Cath Lab, Mammograph, MRI Coils, etc, the minister informed the House. The production of mobiles in value terms has increased by around 146 per cent from Rs 2,13,773 crore in 2020-21 to Rs 5,25,000 crore in 2024-25 as per industry association and DGCIS. During the same period, exports of mobile phones in value terms has increased by around 775 per cent from Rs 22,870 crore in 2020-21 to Rs 2,00,000 crore in 2024-25, he added. 'Cumulative incentive amount of Rs 21,534 crore have been disbursed as on 24.06.2025 under PLI Scheme for 12 sectors, namely Large Scale Electronics Manufacturing (LSEM), IT Hardware, Bulk Drugs, Medical Devices, Pharmaceuticals, Telecom & Networking Products, Food Processing, White Goods, Drones & Drone Components, Specialty Steel, Textile products and Automobiles & Auto components, the minister highlighted.


Hans India
26 minutes ago
- Hans India
Premium homes dominate in India, 62 pc residential sales in H1 2025 over Rs 1 crore
New Delhi: India's housing market is witnessing a strong shift towards premium properties, with 62 per cent of all residential sales in the first half of 2025 coming from homes priced above Rs 1 crore, a new report said on Tuesday. This marks a significant jump from 51 per cent during the same period previous year -- showing growing buyer preference for high-end housing, according to data compiled by JLL. The demand for homes in the Rs 3–5 crore range rose by 14 per cent, while homes priced over Rs 5 crore saw 8 per cent growth compared to H1 2024. This growing tilt towards premium housing has also impacted new project launches. In the first half of 2025, the number of homes priced over Rs 1 crore more than doubled compared to the same period previous year. In Q2 2025 alone, nearly 70,000 homes were sold across India's top seven cities -- registering a 7 per cent growth compared to the previous quarter. Bengaluru, Mumbai, Pune, and Delhi NCR led the way, each recording over 10,000 unit sales. Together, these cities contributed to nearly 77 per cent of the sales in Q2. The high-end housing segment saw strong quarterly growth. Homes priced over Rs 5 crore recorded a 42 per cent jump in demand compared to Q1 2025, while the Rs 3–5 crore category rose by 28 per cent. There's also a growing trend of buyers purchasing newly launched properties. In Q2 2025, about 29 per cent of homes sold were launched in the same quarter, a post-pandemic record. This shows growing trust in top developers who are delivering on promises and offering attractive investment options. Dr. Samantak Das, Chief Economist and Head of Research at JLL India, said the rise in luxury housing reflects increasing buyer affluence and evolving lifestyle needs. Siva Krishnan, Senior Managing Director at JLL, highlighted that despite fewer new project launches overall, premium housing launches soared, especially in Kolkata, Chennai, and Bengaluru. 'A total of 1.54 lakh homes were launched in H1 2025, with a significant share being in the high-end category,' Krishnan stated. Home prices also continued to rise across India's seven major cities during Q2 2025, the report said. Delhi NCR recorded the highest year-on-year (YoY) growth in property prices at 17 per cent, followed by Bengaluru at 14 per cent. These price increases are due to higher construction costs and steady demand. Looking ahead, experts believe that the recent reduction in the repo rate and falling inflation may make home loans cheaper and boost housing demand. 'With better infrastructure, increased urbanisation, and higher consumer spending, the residential market is expected to remain strong,' the report added


Indian Express
26 minutes ago
- Indian Express
IAF to phase out MiG-21 fighter jets in September 2025
The Russian-origin MiG-21 fighter jets are set to be phased out of service in September this year, as per the Indian Air Force plan to replace the remaining squadrons with the indigenously developed Tejas Mark-1A aircraft. In October 2023, the jets participated for the last time in the annual Air Force Day parade. A timeline had been finalised to phase out the Mig-21s then. At a press conference around the same time, Chief of Air Staff Air Chief Marshal V R Chaudhary had said a contract to procure 97 Tejas Mark-1A aircraft at a cost of around Rs 1.15 lakh crore will be concluded soon. This was in addition to the Rs 48,000-crore deal signed with the Hindustan Aeronautics Limited (HAL) in 2021 to procure 83 such jets. 'We will replace the MiG-21 squadrons with the LCA Mark-1A…. The induction of the LCA Mark-1A will fill the gap of the outgoing MiG-21s,' he was quoted as saying by news agency PTI. The MiG-21s were the mainstay of the IAF for a long time since its induction in the early 1960s. The IAF had procured more than 870 MiG-21 fighters to boost its overall combat prowess.